Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Mol Psychiatry. 2023 Apr 25;28(7):2839–2847. doi: 10.1038/s41380-023-02067-2

Table 2. Prospective, pediatric cohorts with repeated measures of methylation and/or imaging.

Cohort Age at baseline Years of follow-up DNAm (number of time points) MRI (number of time points) Sample sizea Reference
Generation R Birth I8y Y(n = 5) Y (n = 4) Up to n = 9778 Kooijman et al. [83]
ALSPAC Birth 24 y Y(n = 7) Y(n = D Up to 15,458 Boyd et al. [84]
FinnBrain Birth 5y Y(n = D Y (n = 2) Up to 3808 Karlsson et al. [85]
GUSTO Birth 3y Y (n = 10) Y (n = 3) Up to 1176 Soh et al. [86]
DCHS Birth 6y Y (n = 4) Y (n = 3) Up to 1143 Donald et al. [87]
NEURON Birth 2y Y (n = 2) Y (n = 2) Up to 80 Moog et al. [88]
Fragile families Birth I5y Y (n = 2) Y(n = D Up to 2020 Reichmann et al. [89]
Lifespan Baby Connectome Project (planned) Birth 5y Y(n = D Y(n = 6) Up to 500 https://www.humanconnectome.org/study/lifespan-baby-connectome-project/overview
IMAGEN I4y 8y Y (n = 2) Y (n = 3) Up to 2463 Schumann et al. [90]
Brazilian High-Risk Cohort 6-14 y 6y Y (n = 3) Y (n = 3) Up to 2512 Salum et al. [91]
a

Sample sizes refer to whole cohort, not limited to the subsample with DNAm or MRI.